The world urgently needs 20 billion doses of a vaccine that will protect global citizens against the coronavirus. States are throwing huge sums of public money at the race to beat Covid-19, but who will get there first? Will Big Pharma focus on private profit? Will vaccine nationalism prevail, or will the patent be shared to create a low-cost global supply?
May 2020
Il Fatto Quotidiano, Italy
5 November 2022
EfSyn, Greece
4 April 2022
Público, Portugal
7 November 2021
EUobserver, Belgium
3 November 2021
taz, Germany
3 November 2021
Der Tagesspiegel, Germany
23 September 2021
EUobserver, Belgium
22 September 2021
Klassekampen, Norway
22 September 2021
Il Fatto Quotidiano, Italy
22 September 2021
Público, Portugal
22 September 2021
Gazeta Wyborcza, Poland
9 May 2021
Público, Portugal
9 May 2021
EfSyn, Greece
9 May 2021
Baricada Bulgaria, Bulgaria
23 March 2021
Baricada Bulgaria, Bulgaria
18 March 2021
Stavanger Aftenblad, Norway
9 March 2021
NRK, Norway
27 August 2020
NRK, Norway
27 August 2020
Basta!, France, Basta!
21 July 2020
Newsweek Poland, Poland
27 May 2020
Republik, Switzerland
20 May 2020
Der Tagesspiegel, Germany
20 May 2020
Falter, Austria
19 May 2020
Il Fatto Quotidiano, Italy
17 May 2020
Público, Portugal
16 May 2020